GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mediera Corp (ROCO:5398) » Definitions » Capital Expenditure

Mediera (ROCO:5398) Capital Expenditure : NT$-0.40 Mil (TTM As of Mar. 2025)


View and export this data going back to 1999. Start your Free Trial

What is Mediera Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Mediera's cash flow for capital expenditures for the three months ended in Mar. 2025 was NT$-0.4 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Mar. 2025 was NT$-0.40 Mil.

Mediera Capital Expenditure Historical Data

The historical data trend for Mediera's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mediera Capital Expenditure Chart

Mediera Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -2.56 -16.65 -2.11 -1.15

Mediera Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -0.40

Mediera Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-0.40 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mediera Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mediera Corp (ROCO:5398) » Definitions » Capital Expenditure
Comparable Companies
ROCO:4117 ROCO:6483 ROCO:6935 ROCO:6677 ROCO:7561 ROCO:6621 ROCO:6496 ROCO:6539 ROCO:1780 ROCO:4127 ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA
Traded in Other Exchanges
N/A
Address
No. 239 Datong Road, Section 1, 16th Floor, Xizhi District, New Taipei, TWN
Website
http://www.mediera.com.tw
Mediera Corp is engaged in domestic research and development, production and manufacturing of various power supply components, and launched its own brand. MEDIERA is also committed to the production of customized products and OEM. It has been more active in the transformation and layout of the development of medical biotechnology. For example, medicines, healthy foods, and medical equipment that greatly help human health have become the focus of development in recent years. In addition, combined with the scientific and technological research and development capabilities of the Electronics Division, advanced The application of electronic micro-control patented technology in electronic medical equipment that can help patients improve their quality of life is a major breakthrough for company.

Mediera Headlines

No Headlines